Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
DexCom Analyst Ratings and Price Targets | NASDAQ:DXCM | Benzinga
DexCom Inc has a consensus price target of $104.36 based on the ratings of 25 analysts. The high is $150 issued by Canaccord Genuity on July 28, 2023. The low is $82 issued by Morgan Stanley on February 14, 2025. The 3 most-recent analyst ratings were released by Barclays, Canaccord Genuity, and Piper Sandler on May 5, 2025, May 2, 2025, and May 2, 2025, respectively. With an average price target of $96.33 between Barclays, Canaccord Genuity, and Piper Sandler, there's an implied 13.51% upside for DexCom Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Canaccord Genuity
Piper Sandler
Baird
Mizuho
1calculated from analyst ratings
Analyst Ratings for DexCom
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/05/2025 | Buy Now | 9.59% | Barclays | Matt Miksic77% | $90 → $93 | Maintains | Equal-Weight | Get Alert |
| 05/02/2025 | Buy Now | 24.9% | Canaccord Genuity | William Plovanic59% | $103 → $106 | Maintains | Buy | Get Alert |
| 05/02/2025 | Buy Now | 6.05% | Piper Sandler | Matt O'Brien52% | $100 → $90 | Maintains | Overweight | Get Alert |
| 05/02/2025 | Buy Now | 23.73% | Baird | Jeff Johnson57% | $115 → $105 | Maintains | Outperform | Get Alert |
| 04/10/2025 | Buy Now | 0.16% | Mizuho | Anthony Petrone66% | → $85 | Initiates | → Outperform | Get Alert |
| 03/04/2025 | Buy Now | 22.55% | Citigroup | Joanne Wuensch79% | $101 → $104 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | 21.37% | Canaccord Genuity | William Plovanic59% | $99 → $103 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | -3.38% | Morgan Stanley | Patrick Wood55% | $75 → $82 | Maintains | Equal-Weight | Get Alert |
| 02/03/2025 | Buy Now | 35.51% | Redburn Atlantic | Issie Kirby33% | $85 → $115 | Upgrade | Neutral → Buy | Get Alert |
| 01/16/2025 | Buy Now | 22.55% | Baird | Jeff Johnson57% | $86 → $104 | Upgrade | Neutral → Outperform | Get Alert |
| 12/11/2024 | Buy Now | 7.23% | Citigroup | Joanne Wuensch79% | $85 → $91 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | 10.76% | Wells Fargo | Larry Biegelsen66% | $90 → $94 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | 16.66% | Canaccord Genuity | William Plovanic59% | $89 → $99 | Maintains | Buy | Get Alert |
| 10/25/2024 | Buy Now | 1.34% | Bernstein | Lee Hambright72% | $82 → $86 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 16.66% | Raymond James | Jayson Bedford70% | $115 → $99 | Maintains | Strong Buy | Get Alert |
| 10/25/2024 | Buy Now | 35.51% | RBC Capital | Shagun Singh43% | $120 → $115 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 23.73% | Oppenheimer | Steven Lichtman59% | $115 → $105 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 0.16% | JP Morgan | Robbie Marcus65% | $75 → $85 | Maintains | Neutral | Get Alert |
| 10/25/2024 | Buy Now | 2.52% | Leerink Partners | Mike Kratky11% | $90 → $87 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 6.05% | Wells Fargo | Larry Biegelsen66% | $80 → $90 | Maintains | Overweight | Get Alert |
| 10/08/2024 | Buy Now | 41.4% | RBC Capital | Shagun Singh43% | $130 → $120 | Maintains | Outperform | Get Alert |
| 08/26/2024 | Buy Now | 6.05% | Piper Sandler | Matt O'Brien52% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 08/23/2024 | Buy Now | 17.83% | Stifel | Mathew Blackman63% | $90 → $100 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | -3.38% | Baird | Jeff Johnson57% | $80 → $82 | Maintains | Neutral | Get Alert |
| 07/29/2024 | Buy Now | 33.15% | Barclays | Matt Miksic77% | $138 → $113 | Maintains | Equal-Weight | Get Alert |
| 07/26/2024 | Buy Now | -5.73% | Baird | Jeff Johnson57% | $161 → $80 | Downgrade | Outperform → Neutral | Get Alert |
| 07/26/2024 | Buy Now | 41.4% | BTIG | Marie Thibault63% | $156 → $120 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | -11.62% | Morgan Stanley | Patrick Wood55% | $120 → $75 | Maintains | Equal-Weight | Get Alert |
| 07/26/2024 | Buy Now | 35.51% | Oppenheimer | Steven Lichtman59% | $150 → $115 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | 11.94% | UBS | Danielle Antalffy62% | $163 → $95 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 6.05% | Stifel | Mathew Blackman63% | $132 → $90 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 6.05% | Piper Sandler | Matt O'Brien52% | $150 → $90 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 70.86% | RBC Capital | Shagun Singh43% | $165 → $145 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | -5.73% | Wells Fargo | Larry Biegelsen66% | $145 → $80 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 4.87% | Canaccord Genuity | William Plovanic59% | $145 → $89 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | -11.62% | JP Morgan | Robbie Marcus65% | $145 → $75 | Downgrade | Overweight → Neutral | Get Alert |
| 07/23/2024 | Buy Now | 70.86% | Canaccord Genuity | William Plovanic59% | $145 → $145 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 41.4% | Morgan Stanley | Patrick Wood55% | $132 → $120 | Maintains | Equal-Weight | Get Alert |
| 07/12/2024 | Buy Now | 55.54% | Stifel | Mathew Blackman63% | $145 → $132 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 53.18% | Redburn Atlantic | Issie Kirby33% | → $130 | Initiates | → Neutral | Get Alert |
| 04/26/2024 | Buy Now | 88.53% | Raymond James | Jayson Bedford70% | $151 → $160 | Maintains | Strong Buy | Get Alert |
| 04/26/2024 | Buy Now | 70.86% | Canaccord Genuity | William Plovanic59% | $144 → $145 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 92.07% | UBS | Danielle Antalffy62% | $153 → $163 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 89.71% | Citigroup | Joanne Wuensch79% | $148 → $161 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 94.43% | RBC Capital | Shagun Singh43% | → $165 | Initiates | → Outperform | Get Alert |
| 01/23/2024 | Buy Now | 77.93% | Raymond James | Jayson Bedford70% | $147 → $151 | Maintains | Strong Buy | Get Alert |
| 01/03/2024 | Buy Now | 73.22% | Raymond James | Jayson Bedford70% | $131 → $147 | Maintains | Strong Buy | Get Alert |
| 12/19/2023 | Buy Now | 76.75% | Piper Sandler | Matt O'Brien52% | $135 → $150 | Maintains | Overweight | Get Alert |
| 12/13/2023 | Buy Now | 60.25% | Wells Fargo | Larry Biegelsen66% | $110 → $136 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | 43.76% | Morgan Stanley | Patrick Wood55% | $101 → $122 | Maintains | Equal-Weight | Get Alert |
| 10/27/2023 | Buy Now | 19.01% | Morgan Stanley | Patrick Wood55% | $98 → $101 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | 17.83% | JP Morgan | Michael Weinstein59% | $160 → $100 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | 29.62% | Leerink Partners | Mike Kratky11% | → $110 | Initiates | → Outperform | Get Alert |
| 10/10/2023 | Buy Now | 70.86% | Stifel | Mathew Blackman63% | $155 → $145 | Maintains | Buy | Get Alert |
| 09/29/2023 | Buy Now | 15.48% | Morgan Stanley | Patrick Wood55% | $131 → $98 | Maintains | Equal-Weight | Get Alert |
| 09/15/2023 | Buy Now | 54.36% | Raymond James | Jayson Bedford70% | $154 → $131 | Maintains | Strong Buy | Get Alert |
| 09/06/2023 | Buy Now | 62.61% | UBS | Danielle Antalffy62% | $175 → $138 | Maintains | Buy | Get Alert |
| 08/21/2023 | Buy Now | 53.18% | Baird | Jeff Johnson57% | $153 → $130 | Maintains | Outperform | Get Alert |
| 07/31/2023 | Buy Now | 62.61% | Barclays | Matt Miksic77% | $115 → $138 | Maintains | Equal-Weight | Get Alert |
| 07/28/2023 | Buy Now | 88.53% | Piper Sandler | Matt O'Brien52% | $150 → $160 | Maintains | Overweight | Get Alert |
| 07/28/2023 | Buy Now | 76.75% | Canaccord Genuity | Kyle Rose55% | $135 → $150 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 81.46% | Raymond James | Jayson Bedford70% | $140 → $154 | Maintains | Strong Buy | Get Alert |
| 07/28/2023 | Buy Now | 80.29% | Baird | Jeff Johnson57% | $145 → $153 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | 76.75% | Citigroup | Joanne Wuensch79% | $146 → $150 | Maintains | Buy | Get Alert |
| 06/26/2023 | Buy Now | 76.75% | BTIG | Marie Thibault63% | $134 → $150 | Maintains | Buy | Get Alert |
| 05/30/2023 | Buy Now | 54.36% | Morgan Stanley | Patrick Wood55% | → $131 | Assumes | → Equal-Weight | Get Alert |
| 05/01/2023 | Buy Now | 35.51% | Barclays | Matt Miksic77% | $110 → $115 | Maintains | Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 64.97% | Stifel | Mathew Blackman63% | $130 → $140 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 57.9% | BTIG | Marie Thibault63% | $132 → $134 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 59.08% | Canaccord Genuity | Kyle Rose55% | $125 → $135 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 64.97% | Raymond James | Jayson Bedford70% | $138 → $140 | Maintains | Strong Buy | Get Alert |
| 04/17/2023 | Buy Now | 55.54% | BTIG | Marie Thibault63% | $126 → $132 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 62.61% | Raymond James | Jayson Bedford70% | $127 → $138 | Upgrade | Outperform → Strong Buy | Get Alert |
| 03/29/2023 | Buy Now | 67.32% | UBS | Danielle Antalffy62% | → $142 | Initiates | → Buy | Get Alert |
| 02/13/2023 | Buy Now | 29.62% | Barclays | Matt Miksic77% | $103 → $110 | Maintains | Equal-Weight | Get Alert |
| 02/10/2023 | Buy Now | 47.29% | Cowen & Co. | Joshua Jennings65% | $114 → $125 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | 42.58% | Wolfe Research | Mike Polark39% | → $121 | Initiates | → Outperform | Get Alert |
| 01/06/2023 | Buy Now | 54.36% | Morgan Stanley | Cecilia Furlong50% | $117 → $131 | Maintains | Equal-Weight | Get Alert |
| 12/12/2022 | Buy Now | 72.04% | Citigroup | Joanne Wuensch79% | $117 → $146 | Maintains | Buy | Get Alert |
| 10/28/2022 | Buy Now | 37.87% | Morgan Stanley | Cecilia Furlong50% | $107 → $117 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | 50.83% | Wells Fargo | Larry Biegelsen66% | $102 → $128 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 47.29% | Raymond James | Jayson Bedford70% | $101 → $125 | Maintains | Outperform | Get Alert |
| 10/18/2022 | Buy Now | 21.37% | Barclays | Matt Miksic77% | → $103 | Initiates | → Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | 47.29% | Jefferies | Matthew Taylor74% | → $125 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 26.08% | Morgan Stanley | Cecilia Furlong50% | $83 → $107 | Maintains | Equal-Weight | Get Alert |
| 10/10/2022 | Buy Now | 29.62% | BTIG | Marie Thibault63% | $92 → $110 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 41.4% | Stifel | Mathew Blackman63% | $112 → $120 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 41.4% | Piper Sandler | Matt O'Brien52% | $110 → $120 | Maintains | Overweight | Get Alert |
| 08/01/2022 | Buy Now | 19.01% | Raymond James | Jayson Bedford70% | $122 → $101 | Maintains | Outperform | Get Alert |
| 07/29/2022 | Buy Now | -2.2% | Morgan Stanley | Cecilia Furlong50% | $91 → $83 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | Buy Now | 29.62% | Piper Sandler | Matt O'Brien52% | $120 → $110 | Maintains | Overweight | Get Alert |
| 07/15/2022 | Buy Now | 23.73% | Bernstein | Lee Hambright72% | → $105 | Initiates | → Outperform | Get Alert |
| 06/24/2022 | Buy Now | 23.73% | BTIG | Marie Thibault63% | $135 → $105 | Maintains | Buy | Get Alert |
| 06/15/2022 | Buy Now | 7.23% | Morgan Stanley | David Lewis71% | $90.75 → $91 | Maintains | Equal-Weight | Get Alert |
| 06/13/2022 | Buy Now | 6.93% | Morgan Stanley | David Lewis71% | $363 → $90.75 | Maintains | Equal-Weight | Get Alert |
| 06/07/2022 | Buy Now | 327.74% | Morgan Stanley | David Lewis71% | $492 → $363 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for DexCom (DXCM) stock?
The latest price target for DexCom (NASDAQ:DXCM) was reported by Barclays on May 5, 2025. The analyst firm set a price target for $93.00 expecting DXCM to rise to within 12 months (a possible 9.59% upside). 40 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DexCom (DXCM)?
The latest analyst rating for DexCom (NASDAQ:DXCM) was provided by Barclays, and DexCom maintained their equal-weight rating.
When was the last upgrade for DexCom (DXCM)?
The last upgrade for DexCom Inc happened on February 3, 2025 when Redburn Atlantic raised their price target to $115. Redburn Atlantic previously had a neutral for DexCom Inc.
When was the last downgrade for DexCom (DXCM)?
The last downgrade for DexCom Inc happened on July 26, 2024 when Baird changed their price target from $161 to $80 for DexCom Inc.
When is the next analyst rating going to be posted or updated for DexCom (DXCM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DexCom, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DexCom was filed on May 5, 2025 so you should expect the next rating to be made available sometime around May 5, 2026.
Is the Analyst Rating DexCom (DXCM) correct?
While ratings are subjective and will change, the latest DexCom (DXCM) rating was a maintained with a price target of $90.00 to $93.00. The current price DexCom (DXCM) is trading at is $84.87, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
